StockCIK 1444192
Grace Therapeutics, Inc. (GRCE): Insider Trades and Fund Holdings
In the past 12 months, Grace Therapeutics, Inc. insiders reported 19 open-market purchases worth $774K and 0 sales worth $0.
19Insider buys, 12 months
$774KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 26 | Opaleye Management Inc.10% owner | ▲ BUY | $117K |
| Oct 26 | Opaleye Management Inc.10% owner | ▲ BUY | $41K |
| Oct 21 | Opaleye Management Inc.10% owner | ▲ BUY | $8K |
| Oct 16 | Opaleye Management Inc.10% owner | ▲ BUY | $69K |
| Oct 16 | Opaleye Management Inc.10% owner | ▲ BUY | $46K |
| Oct 16 | Opaleye Management Inc.10% owner | ▲ BUY | $22K |
| Oct 13 | Opaleye Management Inc.10% owner | ▲ BUY | $15K |
| Oct 13 | Opaleye Management Inc.10% owner | ▲ BUY | $11K |
| Oct 13 | Opaleye Management Inc.10% owner | ▲ BUY | $4K |
| Oct 5 | Opaleye Management Inc.10% owner | ▲ BUY | $79K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 19 GRCE insider trades →Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% owner | 18 | $560K | 0 | $0 |
| Prashant Kohli | CEO | 1 | $214K | 0 | $0 |
Tracked funds that report GRCE
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 0 | $0 | ▼ Sold out |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →